The accumulation of α-synuclein aggregates in gut vagal endings often precedes CNS symptoms in progressive Parkinson’s disease, and recent studies have shown that α-synuclein aggregates injected into the gut can transit to the brain via the vagus nerve [108] (Fig. 2). This evidence concerns the gene SNCA and Parkinson disease.